Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 9/20 | 0.86 |
| ▸ | FNTB | P49356 | 9/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17223966 | 1.00 | FNTA (0.86) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL3271383 | 0.98 | FNTA (0.83) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL11549341 | 0.93 | FNTA (0.79) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL11549345 | 0.93 | FNTA (0.79) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL11551176 | 0.93 | FNTA (0.79) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL11551174 | 0.93 | FNTA (0.79) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL11703920 | 0.93 | FNTA (1.00) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL16792146 | 0.93 | FNTA (1.00) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL9129708 | 0.91 | FNTA (0.96) | FNTAFNTBKMT2AKDM4EATM | |
| SCHEMBL8625937 | 0.91 | FNTA (0.96) | FNTAFNTBKMT2AKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3728174-A1 | SYNTHESIS OF ALKYL 2-ACETYL-5,9,13-TRIMETHYLTETRADECA-4,8,12-TRIENOATES AND DERIVATIVES BY A NON-CONTINUOUS PRODUCTION PROCESS | DSM IP Assets B.V. (NL) | 2020-10-28 | — | — | EP | disclosed |
| EP-3728174-A1 | SYNTHESIS OF ALKYL 2-ACETYL-5,9,13-TRIMETHYLTETRADECA-4,8,12-TRIENOATES AND DERIVATIVES BY A NON-CONTINUOUS PRODUCTION PROCESS | DSM IP Assets B.V. (NL) | 2020-10-28 | — | — | EP | disclosed |
| EP-3137445-B1 | PROCESS FOR THE PREPARATION OF FARNESYL ACETON | BASF SE (DE) | 2019-10-02 | — | — | EP | disclosed |
| WO-2019121134-A1 | SYNTHESIS OF ALKYL 2-ACETYL-5,9,13-TRIMETHYLTETRADECA-4,8,12-TRIENOATES AND DERIVATIVES BY A NON-CONTINUOUS PRODUCTION PROCESS | DSM IP ASSETS B.V. (NL) | 2019-06-27 | — | — | WO | disclosed |
| WO-2019121134-A1 | SYNTHESIS OF ALKYL 2-ACETYL-5,9,13-TRIMETHYLTETRADECA-4,8,12-TRIENOATES AND DERIVATIVES BY A NON-CONTINUOUS PRODUCTION PROCESS | DSM IP ASSETS B.V. (NL) | 2019-06-27 | — | — | WO | disclosed |
| US-10093606-B2 | Method of producing farnesyl acetone | BASF SE (REITSTÖTTER, KINZEBACH & PARTNER) (DE) | 2018-10-09 | — | — | US | disclosed |
| EP-3137445-A1 | METHOD OF PRODUCING FARNESYLACETONE | BASF SE (DE) | 2017-03-08 | — | — | EP | disclosed |
| US-20170044084-A1 | METHOD OF PRODUCING FARNESYL ACETONE | BASF SE (DE) | 2017-02-16 | — | — | US | disclosed |
| WO-2015165959-A1 | METHOD OF PRODUCING FARNESYL ACETONE | BASF SE (DE) | 2015-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10093606-B2 | Method of producing farnesyl acetone | FNTA, FDPS, FNTB | FNTA 1/4885FNTB 3/4885KMT2A 4246/4885 |
| US-20170044084-A1 | METHOD OF PRODUCING FARNESYL ACETONE | FNTA, FDPS, FNTB | FNTA 1/4885FNTB 3/4885KMT2A 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.